Transforming sepsis management: AI-driven innovations in early detection and tailored therapies

Introduction Sepsis remains a major global health challenge due to its complexity and delayed recognition. Artificial intelligence (AI) shows promise in improving early detection, risk prediction, and personalized treatment using…

Continue ReadingTransforming sepsis management: AI-driven innovations in early detection and tailored therapies

Epidemiology and risk factors of fungal pathogens in sepsis: a prospective nationwide multicenter cohort study

Introduction Sepsis is a life-threatening condition, and fungal pathogens are an increasingly important cause, especially in high-risk groups. During COVID-19, fungal co-infections gained significant attention due to their high morbidity…

Continue ReadingEpidemiology and risk factors of fungal pathogens in sepsis: a prospective nationwide multicenter cohort study

New Antibiotics for Treating Infections Caused by Multidrug-Resistant Bacteria

Introduction Antibiotic-resistant bacteria are a growing global threat, causing longer hospital stays, higher costs, and increased mortality. The rise of multidrug-resistant (MDR), extensively drug-resistant (XDR), and pandrug-resistant (PDR) bacteria—such as…

Continue ReadingNew Antibiotics for Treating Infections Caused by Multidrug-Resistant Bacteria

Role of liposomal amphotericin B in intensive care unit: an expert opinion paper

Introduction Invasive fungal infections (IFI) are life-threatening in ICU patients, with rising incidence and persistently high mortality. The increase is linked to complex care needs, immunocompromised states, comorbidities, broad-spectrum antibiotic…

Continue ReadingRole of liposomal amphotericin B in intensive care unit: an expert opinion paper

Current role of ceftobiprole in the treatment of hospital acquired and community acquired pneumonia: expert opinion based on literature and real-life experiences

Introduction (Article introduction authored by INCA Editorial Team) Bacterial pneumonia remains a global health challenge with high morbidity and mortality, particularly in vulnerable populations. Community-acquired pneumonia (CAP) and hospital-acquired pneumonia…

Continue ReadingCurrent role of ceftobiprole in the treatment of hospital acquired and community acquired pneumonia: expert opinion based on literature and real-life experiences

Oral care medications for the prevention and treatment of ventilator-associated pneumonia in intensive care unit

Introduction Ventilator-associated pneumonia (VAP) is a common and serious infection in ICU patients who undergo invasive mechanical ventilation for more than 48 hours. It is caused by various microorganisms, including…

Continue ReadingOral care medications for the prevention and treatment of ventilator-associated pneumonia in intensive care unit

Guidelines for the use of lung ultrasound to optimise the management of neonatal respiratory distress: international expert consensus

Introduction Respiratory distress is the leading cause of NICU admissions. Rapid diagnosis and appropriate treatment are vital for improving outcomes. Mechanical ventilation (MV) is a key therapy but carries risks…

Continue ReadingGuidelines for the use of lung ultrasound to optimise the management of neonatal respiratory distress: international expert consensus